These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 2432080

  • 21. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G, Pürstner P.
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [Abstract] [Full Text] [Related]

  • 22. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
    Khazaeli MB, Buchina ES, Pattillo RA, Soong SJ, Hatch KD.
    Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE, Sweep FC, Schijf CP, Massuger LF, Thomas CM.
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [Abstract] [Full Text] [Related]

  • 27. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM, Kerkmeijer LG, Ariaens HJ, van der Steen RC, Massuger LF, Sweep FC.
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [Abstract] [Full Text] [Related]

  • 28. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA, Schlaerth JB, Ahn C, Sauer MV.
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [Abstract] [Full Text] [Related]

  • 29. Elevated sera levels of SP-1 induced by chemotherapy in patients with metastatic gestational trophoblastic diseases.
    Göcze PM, Than GN, Szabò DG, Csaba IF, Bohn H.
    Oncology; 1990 Sep; 47(5):406-9. PubMed ID: 1699189
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
    Cole LA, Shahabi S, Butler SA, Mitchell H, Newlands ES, Behrman HR, Verrill HL.
    Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH, Cannon W, Benedet JL, Boyes DA.
    Am J Obstet Gynecol; 1977 Apr 01; 127(7):711-2. PubMed ID: 557901
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ, Huang SC, Chow SN, Hsieh CY, Hsu HC.
    Br J Obstet Gynaecol; 1994 Apr 01; 101(4):330-4. PubMed ID: 8199080
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Evaluation of remission in trophoblastic disease as seen from serum hCG level (author's transl)].
    Hirashima N.
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May 01; 32(5):592-600. PubMed ID: 6263999
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.